• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Vitrolife AB (VITR)

Sell: 137.70 SEK|Buy: 137.90 SEK|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Address




Website

https://www.vitrolife.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Vitrolife AB Third Quarter Earnings Result for 20262026-10-22T00:00:00
Vitrolife AB Third Quarter Earnings Conference Call for 20262026-10-22T00:00:00
Vitrolife AB Second Quarter Earnings Result for 20262026-07-16T00:00:00
Vitrolife AB Second Quarter Earnings Conference Call for 20262026-07-16T00:00:00
Vitrolife AB Annual General Meeting for 20262026-05-06T00:00:00
Vitrolife AB First Quarter Earnings Result for 20262026-04-23T00:00:00
Vitrolife AB First Quarter Earnings Conference Call for 20262026-04-23T00:00:00
Vitrolife AB Annual Report for 20252026-03-27T00:00:00
Vitrolife AB Fourth Quarter Earnings Result for 20252026-01-29T00:00:00
Vitrolife AB Fourth Quarter Earnings Conference Call for 20252026-01-29T00:00:00

Previous key dates

NameKey Date
Vitrolife AB Third Quarter Earnings Conference Call for 20252025-10-23T10:00:00
Vitrolife AB Third Quarter Earnings Results for 20252025-10-23T08:00:00
Vitrolife AB Second Quarter Earnings Conference Call for 20252025-07-17T10:00:00
Vitrolife AB Second Quarter Earnings Results for 20252025-07-17T08:00:00
Vitrolife AB Annual General Meeting for 20252025-04-29T16:00:00
Vitrolife AB First Quarter Earnings Conference Call for 20252025-04-24T10:00:00
Vitrolife AB First Quarter Earnings Results for 20252025-04-24T08:00:00
Vitrolife AB Annual Report for 20242025-03-27T00:00:00
Vitrolife AB Fourth Quarter Earnings Conference Call for 20242025-01-30T10:00:00
Vitrolife AB Fourth Quarter Earnings Results for 20242025-01-30T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.